Analyst Ratings Coverage
As of January 11, 2024, Alamos Gold has received 4 analyst updates:
- Scotia Capital maintains an “Outperform” rating with a target price of CAD 20.
- STA Research maintains a “Buy” rating with a target price of CAD 20.
- RBC has raised its target price while maintaining an “Outperform” rating, setting it at CAD 16.
- CIBC World Markets continues to maintain an “Outperform” rating with a target price of CAD 25.
- BMO Capital Markets also maintains an “Outperform” rating with a target price of CAD 23.
Alamos Stock Analysis
As of the latest analysis, the Alamos Gold Inc stock forecast is derived from assessments by 11 analysts. The average analyst target price for Alamos Gold Inc is projected to be CAD 20.63 over the next 12 months, indicating an optimistic outlook on the stock’s potential appreciation.
In terms of the average analyst rating, Alamos Gold Inc is characterized as a “Strong Buy,” suggesting a consensus among analysts that the stock is expected to outperform in the foreseeable future.
However, it’s worth noting that Stock Target Advisor, in its independent stock analysis, holds a “Neutral” stance on Alamos Gold Inc. This neutral rating is based on a combination of 6 positive signals and 7 negative signals identified through their analysis.
As of the latest closing, the stock price of Alamos Gold Inc was CAD 16.86. Over the past week, the stock has experienced a change of -1.58%, while over the past month, it has decreased by -9.89%. Despite short-term fluctuations, the stock has shown resilience over the last year, posting a positive change of +15.01%.
Investors and analysts may interpret these metrics differently, and the divergence between the average analyst rating and Stock Target Advisor’s neutral stance highlights the varied perspectives on Alamos Gold Inc’s future performance. It is crucial for investors to consider multiple sources of analysis and conduct thorough research before making investment decisions.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.